Currently: BPC-157 is not FDA-approved There are no standardized treatment guidelines Long-term human safety data is lacking Large randomized clinical trials have not been completed Optimal dosing protocols have not been established Because most published research comes from animal studies, scientists cannot yet determine whether the same effects occur in humans
Moreover, now, the market features personalized formulations with added vitamins or microdoses of GLP-1s that have never been evaluated as well as patches, gummies and drops that are not actual GLP-1 products
Once it does its job, it becomes oxidized and "inactive." To stay effective, the body must constantly "recycle" it back into its active state
These help ensure that medications are being prescribed appropriately and only when medically necessary
Some other ways people can stay healthy and protect their bones while on GLP-1s include: (Lovelace, NBC News, 3/2
Yes, conceptually
